This federal contract award is for the delivery of Ozempic, a medication used to treat type 2 diabetes, to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $7,013.45, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of November 18, 2024 and was awarded on November 15, 2024. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific order does not have a set-aside designation, indicating open competition.
Generated 2/14/25, 9:36 AM